Related Experiment Video
Updated: Jun 2, 2026
07:03
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Autophagy in nonalcoholic steatohepatitis
1Department of Medicine, Marion Bessin Liver Research Center and Diabetes Research and Training Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Expert Review of Gastroenterology & Hepatology
|April 12, 2011
Summary
Autophagy, a cellular degradation process, plays a key role in liver health. Impaired autophagy may drive nonalcoholic steatohepatitis (NASH) development and progression, suggesting therapeutic potential.
Area of Science:
- Cellular Biology
- Metabolic Disorders
- Hepatology
Background:
- Autophagy is a fundamental cellular process for degrading damaged components via lysosomes.
- Established roles in lipid metabolism, insulin sensitivity, and cellular injury suggest autophagy's involvement in liver disease.
- Nonalcoholic steatohepatitis (NASH) is a complex liver condition characterized by fat accumulation and inflammation.
Purpose of the Study:
- To explore the mechanistic roles of autophagy in the pathogenesis of nonalcoholic steatohepatitis (NASH).
- To investigate how impaired autophagic function contributes to hepatic steatosis and liver injury.
- To assess the therapeutic potential of augmenting hepatic autophagy in NASH.
Main Methods:
- Review of established functions of macroautophagy and chaperone-mediated autophagy in hepatic contexts.
- Analysis of the impact of impaired autophagy on lipid metabolism, insulin sensitivity, and cellular injury.
- Consideration of autophagy's roles in immune responses and carcinogenesis relevant to NASH.
Main Results:
- Decreased autophagic function may promote the initiation of hepatic steatosis.
- Impaired autophagy can accelerate the progression from steatosis to liver injury in NASH.
- Autophagy's functions in immunity and cancer development may also contribute to NASH.
Conclusions:
- Autophagy impairment, associated with lipid accumulation, obesity, and aging, significantly impacts NASH.
- Targeting hepatic autophagy augmentation presents a promising therapeutic strategy for NASH.
- Further research into autophagy modulation could lead to novel NASH treatments.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...